Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Head and Neck Neoplasms
Interventions: Drug: Pemetrexed; Drug: Cetuximab; Drug: Carboplatin; Drug: Cisplatin
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Conditions: Larynx Cancer; Lip Cancer; Oral Cavity Cancer; Pharyngeal Cancer; Oropharyngeal Cancer
Intervention:
Sponsor: University of Kentucky
Recruiting - verified March 2010
Condition: Oral Mucositis
Interventions: Drug: amlexanox; Drug: Vehicle rinse
Sponsors: Access Pharmaceuticals, Inc.; Advanced Clinical Research Services, LLC
Completed - verified March 2010
Conditions: Head and Neck Cancer; Precancerous Condition
Interventions: Biological: cetuximab; Radiation: intensity-modulated radiation therapy
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Head and Neck Cancer
Intervention: Other: Therapy for head and neck cancer
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Head and Neck Cancer
Interventions: Drug: cetuximab; Drug: Cisplatin; Drug: Carboplatin; Drug: 5-fluorouracil
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Condition: Head and Neck Cancer
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Neoplasms, Squamous Cell
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Conditions: Head and Neck Cancer; Lung Cancer; Liver Cancer; Rectal Cancer; Cervical Cancer
Intervention: Drug: [F 18]HX4
Sponsor: Siemens Molecular Imaging
Recruiting - verified February 2010
Condition: Advanced Nasopharyngeal Cancer
Interventions: Drug: Nimotuzumab; Radiation: radiotherapy; Drug: cisplatin
Sponsor: Biotech Pharmaceutical Co.,LTD
Recruiting - verified September 2009
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: FOSCAN
Sponsor: Ministry of Health, Malaysia
Recruiting - verified March 2010
Condition: LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Interventions: Other: RTX + CDDP/5-FU; Other: NO INDUCTION CHT + ( RTX + CETUXIMAB); Other: INDUCTION CHT + ( RTX + CDDP/5-FU); Other: INDUCTION CHT + ( RTX +CETUXIMAB)
Sponsors: Associazione Volontari Pazienti Oncologici; Mario Negri Institute for Pharmacological Research
Recruiting - verified March 2010
Condition: Epidemiology
Intervention:
Sponsor: Tel-Aviv Sourasky Medical Center
Enrolling by invitation - verified March 2010
Conditions: Parathyroid Adenoma; Thyroid Adenoma
Intervention:
Sponsor: Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified March 2010
Condition: Esophageal Cancer
Intervention:
Sponsors: Merck; World Health Information Science Consultants, LLC
Active, not recruiting - verified February 2010
Conditions: Squamous Cell Carcinoma; Adenocarcinoma; Esophageal Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: carboplatin; Drug: Paclitaxel; Drug: Panitumumab; Radiation: 3-D conformal radiation
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified July 2009
Condition: Thyroid Cancer
Intervention: Other: Decision aid exposure
Sponsors: University Health Network, Toronto; Ontario Ministry of Health and Long Term Care; Canadian Institutes of Health Research (CIHR)
Recruiting - verified January 2010
Condition: Thyroid Cancer
Intervention:
Sponsor: National Cancer Institute, Naples
Recruiting - verified February 2010
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Not yet recruiting - verified March 2010
Condition: Pancreatic Cancer
Intervention: Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting - verified March 2010
All Categories ... by Medical Condition » ... Cancers » ... Neck Cancer 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
